C12N 2760/14022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2760/14022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 15 US grants and 19 published applications in this corpus.
Search patents in C12N- Granted patents
- 15
- Published applications
- 19
- Assignees
- 14
- Inventors
- 41
- Latest grant
- 15 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 1 | 2 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 2 | 1 |
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 0 | 1 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 2 |
| 2021 | 1 | 2 |
| 2022 | 1 | 2 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Chimeric molecules and uses thereof15 Oct 2024US 12,116,386 B2The University of Queensland
- Stabilized Filovirus glycoprotein trimers14 Mar 2023US 11,603,390 B2Janssen Vaccines & Prevention B. V.
- Chimeric molecules and uses thereof22 Feb 2022US 11,254,712 B2The University of Queensland
- Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop30 Nov 2021US 11,186,626 B2Integrated Biotherapeutics, Inc.
- Compositions and methods comprising hydrocarbon-stapled polypeptides16 Apr 2019US 10,259,848 B2Dana-Farber Cancer Institute, Inc.
- Vaccines and methods6 Aug 2026US 2026/0224686 A1Cambridge Enterprise Limited
- Chimeric molecules and uses thereof28 Apr 2022US 2022/0127309 A1The University of Queensland
- Vaccines and methods10 Feb 2022US 2022/0040284 A1
- Stabilized filovirus glycoprotein trimers23 Sep 2021US 2021/0292371 A1Janssen Vaccines & Prevention B. V.
- Immune activation triggered by filovirus proteins and polypeptides10 Jun 2021US 2021/0171581 A1University of Hawaii
Most cited
By later US patents
- Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vector8US 8,101,739 B2The United States of America as represented by the Department of Health and Human Services · 2012
- Ebola peptides and immunogenic compositions containing same7US 7,267,823 B2The United States of America as represented by the Secretary of the Army · 2007
- Compositions and methods for detecting, preventing, and treating African Hemorrhagic Fever6US 6,713,069 B1Board of Supervisors of Louisiana State University and Agricultural and Mechanical College · 2004
- Compositions and methods for the treatment of viral infections5US 9,290,545 B2Dana-Farber Cancer Institute, Inc. · 2016
- Compositions and methods comprising hydrocarbon-stapled polypeptides4US 10,259,848 B2Dana-Farber Cancer Institute, Inc. · 2019